Man Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $611K | Sell |
130,849
-44,398
| -25% | -$207K | ﹤0.01% | 1551 |
|
|
2025
Q1 | $962K | Buy |
+175,247
| New | +$962K | ﹤0.01% | 1384 |
|
|
2024
Q2 | – | Sell |
-199,023
| Closed | -$440K | – | 2153 |
|
|
2024
Q1 | $440K | Buy |
+199,023
| New | +$440K | ﹤0.01% | 1700 |
|
|
2022
Q2 | – | Sell |
-439,782
| Closed | -$1.13M | – | 2279 |
|
|
2022
Q1 | $1.13M | Sell |
439,782
-1,218,658
| -73% | -$3.12M | ﹤0.01% | 1326 |
|
|
2021
Q4 | $4.86M | Buy |
1,658,440
+1,622,040
| +4,456% | +$4.75M | 0.02% | 882 |
|
|
2021
Q3 | $89K | Buy |
+36,400
| New | +$89K | ﹤0.01% | 1781 |
|